GlycoMimetics Revenue and Competitors
Estimated Revenue & Valuation
- GlycoMimetics's estimated annual revenue is currently $8.4M per year.
- GlycoMimetics received $119.0M in venture funding in March 2018.
- GlycoMimetics's estimated revenue per employee is $168,840
- GlycoMimetics's total funding is $194.4M.
Employee Data
- GlycoMimetics has 50 Employees.
- GlycoMimetics grew their employee count by 0% last year.
GlycoMimetics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CSO and SVP Research and Co-founder | Reveal Email/Phone |
2 | VP Accounting | Reveal Email/Phone |
3 | VP, Portfolio and Project Management | Reveal Email/Phone |
4 | Controller | Reveal Email/Phone |
5 | General Counsel and Company Secretary | Reveal Email/Phone |
6 | VP Accounting | Reveal Email/Phone |
7 | VP, Clinical Operations | Reveal Email/Phone |
8 | Senior Director, Corporate Development | Reveal Email/Phone |
9 | Director, Facilities, Human Resources and Office Operations | Reveal Email/Phone |
10 | SVP and Chief Business Officer | Reveal Email/Phone |
GlycoMimetics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7M | 35 | -3% | N/A | N/A |
#2 | $7.2M | 36 | -5% | N/A | N/A |
#3 | $10.5M | 52 | -9% | N/A | N/A |
#4 | $344.1M | 1712 | 9% | N/A | N/A |
#5 | $27.5M | 137 | 6% | N/A | N/A |
#6 | $107.3M | 534 | 9% | N/A | N/A |
#7 | $12.9M | 64 | 28% | N/A | N/A |
#8 | $31.6M | 157 | 1% | N/A | N/A |
#9 | $31.4M | 156 | 7% | N/A | N/A |
#10 | $11.5M | 57 | 30% | N/A | N/A |
What Is GlycoMimetics?
At GlycoMimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. Our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow's breakthrough treatments. GlycoMimetics is a clinical-stage biotechnology company. We use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. Since the company's inception in 2003, we have developed a robust, diversified product pipeline. We are a public company traded on the NASDAQ under the symbol GLYC.
keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power
$194.4M
Total Funding
50
Number of Employees
$8.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
GlycoMimetics News
GlycoMimetics Reports Highlights and Financial Results for First Quarter 2022. Thu, April 28, 2022, 4:30 AM ·8 min read. In this article:.
GlycoMimetics: Q1 Earnings Snapshot. April 28, 2022. Comments. ROCKVILLE, Md. (AP) _ GlycoMimetics Inc. (GLYC) on Thursday reported a loss of $14.7 million...
GlycoMimetics press release (NASDAQ:GLYC): Q1 GAAP EPS of -$0.28 beats by $0.03. Cash and cash equivalents of $76.5M. There was no revenue...
The Price to Book ratio for GlycoMimetics, Inc. NasdaqGM:GLYC is 0.841807. The Price to book ratio is the current share price of a company ...
Other Companies in Rockville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.6M | 50 | 9% | N/A |
#2 | $5.8M | 50 | 0% | N/A |
#3 | $7.5M | 50 | 4% | N/A |
#4 | $5.8M | 50 | 11% | N/A |
#5 | $11.7M | 51 | 6% | N/A |
GlycoMimetics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2003-05-23 | $4.3M | 1st | New Enterprise Associates | Article |
| 2004-08-06 | $9.6M | A | Alliance Technology Ventures, Anthem Capital Management | Article |
| 2006-06-26 | $15.4M | Undisclosed | New Enterprise Associates | Article |
| 2009-10-21 | $38.0M | Undisclosed | Genzyme Ventures, New Enterprise Associates | Article |
| 2016-06-20 | $18.6M | Undisclosed | Jefferies LLC | Article |
| 2017-05-25 | $92.6M | Undisclosed | Jefferies LLC | Article |
| 2018-03-21 | $119.0M | Undisclosed | Jefferies | Article |